Updated ISMP Guidelines for Sterile Compounding and Sterile Compounding Technology
In response to a series of serious and fatal compounding errors, the first national Institute on Safe Medication Practices (ISMP) summit was held in 2011. This resulted in the publication of guidelines in 2013 for the preparation of sterile preparations, and this document was subsequently updated in 2016. Learn more about updated guidelines released in May 2022 and some of the concerns that remain.

Results of Survey on National Oncology Drug Shortages
The country is plagued with drug shortages that have negatively impacted patient care. The FDA maintains a drug-shortage database. The American Society of Health-System Pharmacists also have dedicated resources to alert clinicians about this problem. One of the areas in which drug shortages can have the most profound and potentially deadly effect is in oncology. Read more.

IVIG and Kidney Disease: What the Pharmacist Needs to Know
Intravenous immune globulin (IVIG) therapy is used for a host of approved and unapproved immunological indications and is the mainstay of treatment for patients with primary immunodeficiency diseases. IVIG product labeling carries a box warning on the potential for renal dysfunction or acute renal failure in patients predisposed to renal dysfunction. Read more.